SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001595585-19-000257
Filing Date
2019-11-14
Accepted
2019-11-14 16:34:33
Documents
16
Period of Report
2019-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q320198k.htm   iXBRL 8-K 51825
2 EXHIBIT 99.1 q32019financialresults.htm EX-99 140402
8 tricidalogoa03.jpg GRAPHIC 6561
  Complete submission text file 0001595585-19-000257.txt   364965

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20191114.xsd EX-101.SCH 4579
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcda-20191114_cal.xml EX-101.CAL 618
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcda-20191114_def.xml EX-101.DEF 1468
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20191114_lab.xml EX-101.LAB 28366
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20191114_pre.xml EX-101.PRE 14639
12 EXTRACTED XBRL INSTANCE DOCUMENT q320198k_htm.xml XML 4798
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38558 | Film No.: 191220962
SIC: 2834 Pharmaceutical Preparations